{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:12:16Z","timestamp":1780920736134,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","brachyjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.brachy.2023.10.003","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T23:35:20Z","timestamp":1701387320000},"page":"115-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Safe dose escalation and reduction of the fraction number of uterine cervical brachytherapy using a gel spacer in the rectovaginal and vesicouterine septum: A planning study"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9848-9251","authenticated-orcid":false,"given":"Jun","family":"Takatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0660-9987","authenticated-orcid":false,"given":"Naoya","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Muramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Karino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8939-6141","authenticated-orcid":false,"given":"Masaki","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Kosugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terufumi","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Terao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Shikama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2023.10.003_bib0001","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from gynaecological (GYN) GEC-ESTRO working group* (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0002","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy\u20143D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0003","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brachy.2011.07.002","article-title":"American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.10.003_bib0004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brachy.2011.07.003","article-title":"American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.10.003_bib0005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10147-015-0806-7","article-title":"Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer","volume":"20","author":"Ebina","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0006","first-page":"48","article-title":"The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0007","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.prro.2020.04.002","article-title":"Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline","volume":"10","author":"Chino","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0008","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1259\/0007-1285-26-305-252","article-title":"Treatment of cancer of the cervix uteri\u2014a revised \u201cManchester method","volume":"26","author":"Tod","year":"1953","journal-title":"Br J Radiol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0009","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brachy.2019.02.008","article-title":"Compendium of fractionation choices for gynecologic HDR brachytherapy\u2014an American Brachytherapy Society Task Group Report","volume":"18","author":"Albuquerque","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.10.003_bib0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1470-2045(20)30581-7","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial","volume":"22","author":"Fransson","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0011","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: The DBCG HYPO trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0012","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2023.10.003_bib0013","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ijrobp.2019.02.010","article-title":"Five-year outcomes of a single-institution prospective trial of 19-Gy single-fraction high-dose-rate brachytherapy for low- and intermediate-risk prostate cancer","volume":"104","author":"Siddiqui","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0014","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.radonc.2016.05.014","article-title":"Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer","volume":"120","author":"Tanderup","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0015","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ijrobp.2015.04.030","article-title":"Hydrogel spacer prospective multicenter randomized controlled pivotal trial: dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy","volume":"92","author":"Mariados","year":"2015","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0016","first-page":"1","article-title":"Hyaluronic acid spacer for hypofractionated prostate radiation therapy","volume":"02115","author":"Mariados","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0017","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brachy.2020.08.021","article-title":"Configuration analysis of the injection position and shape of the gel spacer in gynecologic brachytherapy","volume":"20","author":"Iijima","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.10.003_bib0018","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/jrr\/rrz016","article-title":"Hyaluronate gel injection for rectum dose reduction in gynecologic high-dose-rate brachytherapy: initial Japanese experience","volume":"60","author":"Kashihara","year":"2019","journal-title":"J Radiat Res"},{"key":"10.1016\/j.brachy.2023.10.003_bib0019","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jrr\/rrs015","article-title":"Eradicative brachytherapy with hyaluronate gel injection into pararectal space in treatment of bulky vaginal stump recurrence of uterine cancer","volume":"53","author":"Kishi","year":"2012","journal-title":"J Radiat Res"},{"key":"10.1016\/j.brachy.2023.10.003_bib0020","article-title":"Effect of hyaluronate acid injection on dose-volume parameters in brachytherapy for cervical cancer","volume":"7","author":"Kobayashi","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0021","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brachy.2019.11.004","article-title":"Hyaluronic acid gel injection in rectovaginal septum reduced incidence of rectal bleeding in brachytherapy for gynecological malignancies","volume":"19","author":"Murakami","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.10.003_bib0022","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/jrr\/rrac031","article-title":"Now is it time to implement spacers in cervical cancer brachytherapy?","volume":"63","author":"Murakami","year":"2022","journal-title":"J Radiat Res"},{"key":"10.1016\/j.brachy.2023.10.003_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/jcb.2019.82612","article-title":"Hyaluronic gel injection into the vesicovaginal septum for high-dose-rate brachytherapy of uterine cervical cancer: an effective approach for bladder dose reduction","volume":"11","author":"Murakami","year":"2019","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2023.10.003_bib0024","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1200\/JCO.2012.47.9931","article-title":"Novel use of a hydrogel spacer permits reirradiation in otherwise incurable recurrent gynecologic cancers","volume":"31","author":"Viswanathan","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0025","article-title":"MucoUp\u00ae as a spacer in brachytherapy for uterine cervical cancer: a first-in-human experience","volume":"42","author":"Muramoto","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0026","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/jrr\/rrw109","article-title":"Recommendations for high-risk clinical target volume definition with computed tomography for three-dimensional image-guided brachytherapy in cervical cancer patients","volume":"58","author":"Ohno","year":"2017","journal-title":"J Radiat Res"},{"key":"10.1016\/j.brachy.2023.10.003_bib0027","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1118\/1.598439","article-title":"Comment on \u201cdosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43","volume":"25","author":"Fung","year":"1998","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2023.10.003_bib0028","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ygyno.2015.02.025","article-title":"Seeing is saving: the benefit of 3D imaging in gynecologic brachytherapy","volume":"138","author":"Viswanathan","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0029","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.brachy.2022.10.006","article-title":"Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic","volume":"22","author":"Chopra","year":"2023","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.10.003_bib0030","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.brachy.2022.03.003","article-title":"Brachytherapy workflow for locally advanced cervical cancer: a survey of Canadian medical physicists","volume":"21","author":"Menon","year":"2022","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.10.003_bib0031","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ygyno.2021.07.021","article-title":"Why not de-intensification for uterine cervical cancer?","volume":"163","author":"Murakami","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0032","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.brachy.2022.12.005","article-title":"Outcomes from a 3-fraction high-dose-rate brachytherapy regimen for patients with cervical cancer","volume":"22","author":"Williamson","year":"2023","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.10.003_bib0033","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0034","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5114\/jcb.2020.100382","article-title":"Transvaginal artificial ascites infusion as a spacer in gynecological brachytherapy: a novel technique","volume":"12","author":"Karube","year":"2020","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2023.10.003_bib0035","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.radonc.2021.05.010","article-title":"IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer","volume":"160","author":"Mahantshetty","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.10.003_bib0036","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijrobp.2014.06.005","article-title":"Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer","volume":"90","author":"Viswanathan","year":"2014","journal-title":"Int J Radiat Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472123016768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472123016768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T10:56:53Z","timestamp":1711191413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472123016768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1538472123016768"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2023.10.003","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safe dose escalation and reduction of the fraction number of uterine cervical brachytherapy using a gel spacer in the rectovaginal and vesicouterine septum: A planning study","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2023.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}